Skip to main content

Increase in Hepatitis A Vaccination Needed to Prevent Deaths

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Oct. 25, 2023 -- Nearly two-thirds of those with hepatitis A virus (HAV)-related deaths have at least one documented indication for HAV vaccine, and only 4 percent have evidence of vaccination, according to research published in the Oct. 20 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Megan G. Hofmeister, M.D., from the CDC in Atlanta, and colleagues analyzed data from 27 HAV outbreak-affected states that contributed data during Aug. 1, 2016, to Oct. 31, 2022, to characterize demographic, risk factor, clinical, and cause-of-death data among 315 outbreak-related HAV deaths.

The researchers found that on 60 percent of available death certificates, HAV was documented as an underlying or contributing cause of death. There was a peak in outbreak-related deaths in 2019, which then decreased annually through 2022. The median age at death was 55 years; 73 and 84 percent of deaths occurred among males and non-Hispanic Whites, respectively. Overall, 63 percent of decedents had at least one documented indication for HAV vaccination, including drug use, homelessness, or coinfection with hepatitis B or hepatitis C (41, 16, 12, and 31 percent, respectively); evidence of previous HAV vaccination was seen for 4 percent.

"As of October 2023, 34 states have declared ends to their outbreaks; however, many susceptible adults, particularly among persons who use drugs, persons experiencing homelessness, and persons with chronic liver disease, remain at increased risk for HAV infection or severe disease from HAV infection," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Mortality in Rheumatic Heart Disease Is High

FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June...

Higher County-Level Prostate Cancer Screening Tied to Better Outcomes

FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...

Metabolic Impact on Offspring Similar for Frozen, Fresh Embryo Transfer

FRIDAY, June 7, 2024 -- For glucose and lipid profiles during early childhood, the impact of frozen embryo transfer (FET) is comparable to that of fresh embryo transfer, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.